المؤلفون: Berk M; Department of Clinical and Biomedical Sciences, Barwon Health, The University of Melbourne, Geelong, Melbourne, Victoria, Australia., Fitzsimons J, Lambert T, Pantelis C, Kulkarni J, Castle D, Ryan EW, Jespersen S, McGorry P, Berger G, Kuluris B, Callaly T, Dodd S

المصدر: CNS drugs [CNS Drugs] 2007; Vol. 21 (2), pp. 117-27.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9431220 Publication Model: Print Cited Medium: Print ISSN: 1172-7047 (Print) Linking ISSN: 11727047 NLM ISO Abbreviation: CNS Drugs Subsets: MEDLINE

مواضيع طبية MeSH: Antipsychotic Agents/*adverse effects , Antipsychotic Agents/*blood , Clozapine/*adverse effects , Clozapine/*blood, Agranulocytosis/chemically induced ; Antipsychotic Agents/therapeutic use ; Australia/epidemiology ; Clozapine/therapeutic use ; Consensus ; Diabetes Mellitus/chemically induced ; Humans ; Hyperlipidemias/chemically induced ; Neutropenia/chemically induced ; Population Surveillance ; Psychotic Disorders/drug therapy ; Weight Gain/drug effects